AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04499326 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Validated quality of life questionnaire (EQ-5D & C-CAP)
Description: Patient quality of life to be assessed at baseline, 1, 2, 3, 4, 6, 9 and 12 months
Study NCT04499326 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Validated quality of life questionnaire (EQ-5D & C-CAP)
Description: Patient quality of life to be assessed at baseline, 1, 2, 3, 4, 6, 9 and 12 months
Study NCT04558619 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Kōmmour Prenatal
Description: Centering Pregnancy, a group prenatal care model, is a promising intervention that challenges the standard model of one-on-one counseling of prenatal care. The model, is currently implemented at the UAMS, but as of yet to be adapted for Pacific Islanders. Centering Pregnancy replaces the individual prenatal care visit with a group model for obstetrically low-risk women. This model provides substantially more health promotion content than the traditional one-on-one prenatal care model. The intervention occurs from week 14 of pregnancy through birth, following the same same schedule as individual care. Group visits are 90-120 minutes each and follow a unique structured curriculum that incorporates standards of care. In the group setting, credentialed prenatal providers conduct a one-on-one assessment with each patient (30 min) and then facilitate group discussions on the topics of pregnancy, using adult learning principles (60-90 min).
Study NCT04050735 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alcohol, ethyl, moderate dose
Description: Moderate oral dose of ethyl alcohol
Study NCT04050735 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo beverage
Study NCT04693767 — intervention group
Intervention type: DEVICE
Intervention: Mechanical thrombectomy
Description: 1. Clot specimen collection~2. Extracranial blood collection
Study NCT06042010 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral zinc supplement
Description: patients received oral Zinc picolinate 50mg for 6 weeks as single morning dose along with 0.1%
Study NCT06042010 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: triamcinolone acetonide Oral paste
Description: patients will received 0.1%triamcinolone acetonide Oral paste twice daily alone for 6weeks.
Study NCT05321888 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mechanical Ventilation
Description: Standard Protocol
Study NCT05321888 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mechanical Ventilation with Postural drainage
Description: This Group will be treated by postural drainage and mechanical ventilation for two consecutive days
Study NCT06455150 — intervention group
Intervention type: OTHER
Intervention: Assessment of pelvic floor dysfunctions' symptoms and sings, pelvic floor muscle strength and quality of life
Description: It will be assessed the presence of urinary incontinence, anal incontinence, pelvic organ prolapse and female sexual dysfunction' symptoms by using the questionaries validated to Spanish population International Consultation on Incontinence Questionnaire-Short Form, Pelvic Floor Distress Inventory Short Form and Female Sexual Function Index; in addition, the sign of stress urinary incontinence and pelvic organ prolapse will be assessed by using the cough stress test and Pelvic Organ Prolapse Quantification System, the pelvic floor muscle strength by using manometry, and quality of life by using SF-12 questionnaire.
Study NCT06312280 — intervention group
Intervention type: BEHAVIORAL
Intervention: Mediterranean diet
Description: The composition of the diet will be distributed as follows: 55-60% of carbohydrates (45-50% complex carbohydrates and no more than 10% of simple sugars), 25-30% of lipids and 15% of proteins. It will be studied in accordance with the LARN (Italian Society of Human Nutrition, 2014) guidelines.
Study NCT06353438 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Program
Description: Concentric strengthening of multiple muscle groups 2x/week for 6 weeks.
Study NCT05137353 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Training (RitMoZ Training)
Description: This training is inspired by intervention concepts followed in SUVAG Polyclinic in Zagreb, Croatia and Kodaly pedagogy in Hungary. RitMoZ Training programme consists of 6 main activities: matching activity, nursery rhymes, rhythmic stimulations, music shapes, music writing and music reading. The training focuses on the perceptual overlap between language and music, embodiment and entrainment. The aim of the training is to improve characteristic features of reading disorders such as phonological awareness, perception of rhythm, phonological working memory and perception of speech sounds.
Study NCT05137353 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Spelling Training
Description: This training consists of activities which focus on practicing spelling words in a computer task; the aim is to train orthographic processing which is suggested to improve phonological awareness and phonological working memory.
Study NCT04647630 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: urine test
Description: test for pneumococcal antigen in urine
Study NCT05854433 — intervention group
Intervention type: OTHER
Intervention: Non-interventional study
Description: No intervention will be administered as part of this study.
Study NCT05003960 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AlloRx
Description: cultured allogeneic adult umbilical cord derived mesenchymal stem cells
Study NCT04667078 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cangrelor
Description: administration of cangrolor by iv befor thrombectomy
Study NCT04667078 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: best medical management
Description: used yhe best medical management
Study NCT05872360 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Bundle Group 1 with Nutrilite Lifestyle
Description: All-plant protein booster: 2 spoons (15g), twice per day. Calcium \& Magnesium：3 tablets one time per day. Glucosamine: 2 tablets two times per day. 20 minutes training with EMS (Electric Muscle Stimulation) per day. Practice according to Nutrilite Lifestyle Guideline per day.
Study NCT05872360 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Bundle Group 2 without Nutrilite Lifestyle
Description: All-plant protein booster: 2 spoons (15g), twice per day. Calcium \& Magnesium：3 tablets one time per day. Glucosamine: 2 tablets two times per day. 20 minutes training with EMS (Electric Muscle Stimulation) per day.
Study NCT05872360 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control Group 1
Description: Placebo: 2 spoons (15g), twice per day. Placebo for Calcium \& Magnesium：3 tablets one time per day. Placebo for Glucosamine: 2 tablets two times per day.
Study NCT05872360 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control Group 2 with Nutrilite Lifestyle
Description: Placebo: 2 spoons (15g), twice per day. Placebo for Calcium \& Magnesium：3 tablets one time per day. Placebo for Glucosamine: 2 tablets two times per day. Practice according to Nutrilite Lifestyle Guideline per day.
Study NCT04693767 — intervention group
Intervention type: OTHER
Intervention: Minimally invasive surgery
Description: 1. Clot specimen collection~2. Arterial blood collection
Study NCT06451406 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Selective serotonin re-uptake inhibitor
Description: Patients received selective serotonin re-uptake inhibitor as medical treatment for treatment of premature ejaculate.
Study NCT06451406 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Description: Patients received injection of glans penis with hyaluronic acid
Study NCT06651684 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CanCEASE with Health Navigator
Description: CanCEASE is a digital intervention to identify parents who smoke, assess their motivation and willingness to quit, as well as to provide direct linkage to evidence-based smoking interventions, including effective behavioural and pharmacological resources that can be used alone or in combination.~Participants will have the choice to receive CanCEASE at three timepoints (0, 6 and 12 months). CanCEASE will be combined with an offer of support sessions with a Health Navigator.~Health Navigators will be research personnel hired specifically for this study and trained formally in health navigation, tobacco cessation counseling and strategies to address unmet social needs. The investigators will leverage knowledge and experience of two ongoing RCTs of HNs in pediatrics to inform training strategies.
Study NCT06653972 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegylated Liposomal Doxorubicin + vinorelbine,every cycle is 14d.
Description: Pegylated Liposomal Doxorubicin 25mg/m2 ivgtt d1 + vinorelbine25mg/m2 ivgtt d1/q14d.
Study NCT06655350 — intervention group
Intervention type: OTHER
Intervention: MRI
Description: Morphological data on the tendon (appearance) will be collected on the harvested side and on the healthy side from an MRI analysis carried out systematically after Haemi-Castaing-type surgery.
Study NCT06655350 — intervention group
Intervention type: OTHER
Intervention: Measure
Description: Morphological data on the tendon (diameter) will be collected on the harvested side and on the healthy side from an MRI analysis carried out systematically after Haemi-Castaing-type surgery.
Study NCT06655805 — intervention group
Intervention type: DEVICE
Intervention: Non-invasive ventilation, Invasive mechanical ventilation, high-flow nasal oxygen
Description: No intervention is intended by the nature of this observational study.
Study NCT06590818 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High tibial osteotomy (HTO
Description: To investigate the effect of body mass index (BMI) on the early efficacy of high tibial osteotomy (HTO) in the treatment of varus knee osteoarthritis
Study NCT06597123 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Basic AI (artificial intelligence)-Augmented Motivational Interviewing Training
Description: Basic participants will participate in two motivational interviewing (MI) training sessions that involve role-play practice of MI. Artificial intelligence (AI) will be used to provide metrics on MI-skills (percentage of the time the clinician talks, use of open-ended questions, use of closed-ended questions, use of reflective statements, use of 0-10 scales) as measured by the ReadMI™ tool (Real-time Evaluation of Dialogue in Motivational Interviewing), and both the spirit of MI and presence of bias as measured by Dougall GPT.
Study NCT06597123 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Plus AI (artificial intelligence)-Augmented Motivational Interviewing Training
Description: Plus participants will participate in four motivational interviewing (MI) training sessions that involve role-play practice of MI. Artificial intelligence (AI) will be used to provide metrics on MI-skills (percentage of the time the clinician talks, use of open-ended questions, use of closed-ended questions, use of reflective statements, use of 0-10 scales) as measured by the ReadMI™ tool, and both the spirit of MI and presence of bias as measured by Dougall GPT.
Study NCT06594029 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Navigator Intervention
Description: see previous section
Study NCT06594029 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: Participants receive information on how to increase their community participation
Study NCT06597890 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: educational content (sleep hygiene)
Description: app-based sleep hygiene-related educational content
Study NCT06597890 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: sleep hygiene strategies
Description: app-based self-selection of sleep hygiene strategies
Study NCT06597890 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: reminders
Description: daily reminders sent via push notifications
Study NCT06597890 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: review of behavioural goal
Description: app-based review of behavioural goal
Study NCT06597890 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: educational content (sleep guidelines)
Description: app-based educational content on recommended sleep guidelines
Study NCT06597890 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: comparison of current behaviour to ideal behaviour
Description: use of smartwatch/smartphone data to assess current behaviour and compare it to ideal behaviour
Study NCT06597890 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: goal setting
Description: prompt participant to set a goal in relation to targeted behaviour
Study NCT06597890 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: educational content (Vigorous Intermittent Lifestyle Physical Activity (VILPA))
Description: app-based educational content on VILPA
Study NCT06597890 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: screentime breaks
Description: repeated daily reminders to break up screentime
Study NCT06587503 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BioNTech - Pfizer COVID-19 vaccine
Description: Vaccine for protection from COVID-19
Study NCT06587503 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: 1mL saline solution
Description: Placebo
Study NCT06587503 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rVSV∆G-ZEBOV-GP
Description: Vaccine for protection from Zaire Ebola virus
Study NCT06587503 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: rVSV∆G-ZEBOV-GP
Description: Vaccine for protection from Zaire Ebola virus
Study NCT06587945 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nicotinamide Riboside
Description: Oral Nicotinamide Riboside, 2g daily for 4 weeks followed by 1g daily for 16 weeks
Study NCT06587945 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo
Study NCT06587945 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vitrectomy and Gas tamponade
Description: Standard of care Vitrectomy surgery for retinal reattachment
Study NCT06587945 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Vitrectomy and Gas tamponade
Description: Standard of care Vitrectomy surgery for retinal reattachment
Study NCT06600724 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Beginning at the screening visit, participants will receive weekly treatment with standard of care (cleaning, debridement, ulcer moisture balance, and offloading) until ulcer closure, or a maximum of 12 weeks, whichever occurs first.
Study NCT06600724 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EPIEFFECT
Description: Participants will receive weekly applications of EPIEFFECT and Standard of Care until ulcer closure, or a maximum of 12 weeks, whichever occurs first
Study NCT06600724 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EPIXPRESS
Description: Participants will receive weekly applications of EPIXPRESS and Standard of Care until ulcer closure, or a maximum of 12 weeks, whichever occurs first
Study NCT06093126 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lemborexant 5 MG
Description: The participant will receive 8 weeks of treatment Week 1 = placebo Week 2 = lemborexant 5mg Week 3 = lemborexant 10 mg Week 4 = placebo Week 5 = lemborexant 10 mg Week 6 = placebo Week 7 = placebo Week 8 = lemborexant 10 mg
Study NCT06599541 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hypopressive Exercise
Description: A hypopressive exercise program will be carry out.
Study NCT06599541 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pilates Exercise
Description: A pilates exercise program will be carry out.
Study NCT03390920 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Umbilical Allograft
Description: The umbilical allograft is regulated by the FDA and comes from a lab that is FDA registered.
Study NCT06591117 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vizio Aqueous Microshunt
Description: Ocular microshunt placement for the treatment of Glaucoma
Study NCT06591195 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Distraction by use of kaleidoscope
Description: À kaleidoscope is an optical device consisting of mirrors that reflect images of bits of coloured glass in a symmetrical geometric design through a viewer.~A kaleidoscope was selected as the non-electronic method of distraction, because of its wide availability due to low costs, its evolving and colourful visual stimuli, the fact that is blocks out any visualisations from the environment when used properly, and because it requires active participation (i.e., greater attention) from the subject.
Study NCT06654635 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rhomboid intercostal plane block
Description: The patients in this group will receive ultrasound -guided rhomboid intercostal plane block after induction of general anesthesia. The rhomboid intercostal block will be performed at the T6 levels, bilaterally.
Study NCT06654635 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block
Description: The patients in this group will receive ultrasound -guided Erector spinae plane block after induction of general anesthesia. Erector spinae plane block will be performed at the level of T9 bilaterally.
Study NCT05788393 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine Injection [Precedex]
Description: dexmedetomidine group will receive continuous intraoperative dexmedetomidine IV infusion \[1ug/kg dexmedetomidine over 15 min as a loading dose and 0.5ug/kg/h for maintenance\].The continuous intraoperative IV infusion of study drug will be stopped 10 min before the end the surgical procedure.
Study NCT05788393 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine IV
Description: lidocaine group will receive continuous intraoperative lidocaine IV infusion \[1.5 mg/kg lidocaine over 15 min as a loading dose and 1.5 mg/kg/h for maintenance\]. The continuous intraoperative IV infusion of study drug will be stopped 10 min before the end the surgical procedure.
Study NCT04700722 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Skin Biopsy
Description: Test accuracy and precision of skin biopsy detection of phosphorylated α-synuclein, define sensitivity and specificity of skin biopsy detection of phosphorylated α-synuclein deposition for the diagnosis of synucleinopathies and to differentiate between the synucleinopathies by quantitative measurement of phosphorylated α-synuclein with skin biopsies.
Study NCT04035174 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: LTS-2 DEC patch
Description: After 24 hours, the patch will be removed, and then the reaction of the skin under the device will be assessed : no reaction, weak reaction (\< 50% skin surface under the patch), medium reaction (> 50% skin surface under the patch), and important reaction (reaction on all the surface of the skin under the patch).
Study NCT04035174 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: LTS-2 DEC patch
Description: After 24 hours, the patch will be removed, and then the reaction of the skin under the device will be assessed : no reaction, weak reaction (\< 50% skin surface under the patch), medium reaction (> 50% skin surface under the patch), and important reaction (reaction on all the surface of the skin under the patch).
Study NCT04035174 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Skin snips
Description: Regarding skin snips, a reading will be done at 24 hours after incubation of the skin in saline serum during 24 hours.
Study NCT04035174 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Skin snips
Description: Regarding skin snips, a reading will be done at 24 hours after incubation of the skin in saline serum during 24 hours.
Study NCT04834206 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Docetaxel, nedaplatin, fluorouracil
Description: Induction chemotherapy. Docetaxel 60 mg/m2 intravenous day1. Nedaplatin 60 mg/m2 intravenous day1. Fluorouracil 3000 mg/m2 continuous intravenous infusion 120 hours from day1. Every 21 days, 3 cycles.
Study NCT04834206 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: IMRT
Description: Intensity modulated-radiotherapy (IMRT) is given as 2.0-2.33 Gy per fraction with five daily fractions per week for 6-7 weeks to a total dose of 66 Gy or greater to the primary tumor.
Study NCT04834206 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Nedaplatin
Description: Concurrent chemotherapy. nedaplatin 100 mg/m2 intravenous at day1, 22, 43 of radiotherapy.
Study NCT04268524 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: drug: miltefosine with thermotherapy
Description: see previous
Study NCT04268524 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: drug: miltefosine with thermotherapy
Description: see previous
Study NCT06654635 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control group
Description: No block will be performed, and patient will receive general anesthesia (GA) only.
Study NCT06655584 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality headset Bliss DTX
Description: The patient will be installed in a reception room and will benefit from Bliss DTx digital therapy via a video headset and an audio headset for a duration of 13 minutes
Study NCT05570123 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Flexofytol Forte
Description: standardized exclusive dry extracts of Curcuma longa and Boswellia serrata. 2 tablets a day, one in the morning, one in the evening